Zrepag MF 2mg/500mg Tablet
Marketer
Daylon Healthcare
Salt Composition
Repaglinide (2mg) + Metformin (500mg)
Overview Zrepag MF 2mg/500mg Tablet
Diabexe Duo 2mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabexe Duo with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continuous use is crucial, even with controlled blood sugar; abrupt cessation, without medical consultation, risks elevated glucose levels and potential complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods or juice) is essential. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. Contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests assessing blood cell counts and liver function, are recommended.
Primary Ingredients of Zrepag MF 2mg/500mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Zrepag MF 2mg/500mg Tablet
Managing type 2 diabetes
Major Benefits of Zrepag MF 2mg/500mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 2mg/500mg Zrepag MF Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Zrepag MF 2mg/500mg Tablet:
- Hypoglycemia (low blood glucose level)
- Sweating
- Dizziness
- Diarrhea
- Loss of appetite
- Nausea
- Stomach pain
- Taste change
- Weight gain
How to use Zrepag MF 2mg/500mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Zrepag MF 2mg/500mg Tablet with a meal.
How Zrepag MF 2mg/500mg Tablet works:
Each Zrepag MF 2mg/500mg tablet contains a dual antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Zrepag MF 2mg/500mg tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Zrepag MF 2mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks before prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
The use of Zrepag MF 2mg/500mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Zrepag MF 2mg/500mg tablets, potentially requiring dosage modification. Medical advice is essential. The use of Zrepag MF 2mg/500mg tablets is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Zrepag MF 2mg/500mg tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Zrepag MF 2mg/500mg Tablet :
NA
Facts to Know About Zrepag MF 2mg/500mg Tablet
| Label | Value |
|---|---|
| Addictive | No. |
| Treatment Category | Diabetes Medication |
3,018 People bought this recently